Back to Agenda
Session 1A: Workshop on Benefit-Risk Assessment in PSUR: Discussion on Practices
Session Chair(s)
![Sarah Morgan](/_Images/member/Generic_Image_Missing-Profile.jpg)
Sarah Morgan
Benefit-Risk Management Group Manager
MHRA, United Kingdom
Doris Irene Stenver, MD, MPA
Independent Pharmacovigilance Adviser
Unique Advice, Denmark
Have an account?